These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12975596)

  • 21. Clinical and genetic characterization of patients with hypertrophic cardiomyopathy and right atrial enlargement.
    Limongelli G; Masarone D; Frisso G; Iacomino M; Ferrara I; Rea A; Gravino R; Bossone E; Salvatore F; Calabro R; Elliott P; Pacileo G
    J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):249-254. PubMed ID: 26808413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cardiomyopathy in Friedreich's ataxia - New biomarker for staging cardiac involvement.
    Weidemann F; Liu D; Hu K; Florescu C; Niemann M; Herrmann S; Kramer B; Klebe S; Doppler K; Üçeyler N; Ritter CO; Ertl G; Störk S
    Int J Cardiol; 2015 Sep; 194():50-7. PubMed ID: 26005806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectrum and significance of electrocardiographic patterns, troponin levels, and thrombolysis in myocardial infarction frame count in patients with stress (tako-tsubo) cardiomyopathy and comparison to those in patients with ST-elevation anterior wall myocardial infarction.
    Sharkey SW; Lesser JR; Menon M; Parpart M; Maron MS; Maron BJ
    Am J Cardiol; 2008 Jun; 101(12):1723-8. PubMed ID: 18549847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac findings in asymptomatic chronic hemodialysis patients with persistently elevated cardiac troponin I levels.
    Katerinis I; Nguyen QV; Magnin JL; Descombes E
    Ren Fail; 2008; 30(4):357-62. PubMed ID: 18569907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients.
    Atkison P; Joubert G; Barron A; Grant D; Paradis K; Seidman E; Wall W; Rosenberg H; Howard J; Williams S
    Lancet; 1995 Apr; 345(8954):894-6. PubMed ID: 7535875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tacrolimus Predose Concentration Is Associated With Hypertension in Pediatric Liver Transplant Recipients.
    Prytula A; Vandekerckhove K; Raes A; De Wolf D; Dehoorne J; Vande Walle J; De Bruyne R
    J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):616-623. PubMed ID: 26910645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of tacrolimus-induced cardiomyopathy.
    Coley KC; Verrico MM; McNamara DM; Park SC; Cressman MD; Branch RA
    Ann Pharmacother; 2001 Sep; 35(9):985-9. PubMed ID: 11573873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinically Significant Drug Interaction Between Clotrimazole and Tacrolimus in Pancreas Transplant Recipients and Associated Risk of Allograft Rejection.
    Viesselmann CW; Descourouez JL; Jorgenson MR; Radke NA; Odorico JS
    Pharmacotherapy; 2016 Mar; 36(3):335-41. PubMed ID: 26877191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes.
    deFilippi CR; Tocchi M; Parmar RJ; Rosanio S; Abreo G; Potter MA; Runge MS; Uretsky BF
    J Am Coll Cardiol; 2000 Jun; 35(7):1827-34. PubMed ID: 10841231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease. Comparison with exercise electrocardiography.
    Severi S; Picano E; Michelassi C; Lattanzi F; Landi P; Distante A; L'Abbate A
    Circulation; 1994 Mar; 89(3):1160-73. PubMed ID: 8124803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens.
    Felix MJ; Felipe CR; Tedesco-Silva H; Osmar Medina-Pestana J
    Pharmacotherapy; 2016 Feb; 36(2):152-65. PubMed ID: 26799522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine A in Reperfused Myocardial Infarction: The Multicenter, Controlled, Open-Label CYCLE Trial.
    Ottani F; Latini R; Staszewsky L; La Vecchia L; Locuratolo N; Sicuro M; Masson S; Barlera S; Milani V; Lombardi M; Costalunga A; Mollichelli N; Santarelli A; De Cesare N; Sganzerla P; Boi A; Maggioni AP; Limbruno U;
    J Am Coll Cardiol; 2016 Feb; 67(4):365-374. PubMed ID: 26821623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between discharge heart rate and left ventricular adverse remodelling in ST segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Joyce E; Hoogslag GE; Leong DP; Fox K; Schalij MJ; Marsan NA; Bax JJ; Delgado V
    Heart; 2013 Apr; 99(8):556-61. PubMed ID: 23468514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
    Kuypers DR; Vanrenterghem Y
    Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes.
    Everett BM; Brooks MM; Vlachos HE; Chaitman BR; Frye RL; Bhatt DL;
    N Engl J Med; 2015 Aug; 373(7):610-20. PubMed ID: 26267622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study.
    Ho CY; Day SM; Colan SD; Russell MW; Towbin JA; Sherrid MV; Canter CE; Jefferies JL; Murphy AM; Cirino AL; Abraham TP; Taylor M; Mestroni L; Bluemke DA; Jarolim P; Shi L; Sleeper LA; Seidman CE; Orav EJ;
    JAMA Cardiol; 2017 Apr; 2(4):419-428. PubMed ID: 28241245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The incidence of post-transplant cancer among kidney transplant recipients is associated with the level of tacrolimus exposure during the first year after transplantation.
    Lichtenberg S; Rahamimov R; Green H; Fox BD; Mor E; Gafter U; Chagnac A; Rozen-Zvi B
    Eur J Clin Pharmacol; 2017 Jul; 73(7):819-826. PubMed ID: 28342067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between tacrolimus and erythromycin.
    Padhi ID; Long P; Basha M; Anandan JV
    Ther Drug Monit; 1997 Feb; 19(1):120-2. PubMed ID: 9029762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.